🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized，multicenter, open-label Phase III, clinical study is conducted...
Status
Recruiting
Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Start Date
2023-03-03
Trial ID
NCT05586074
Treatments Being Tested
The goal of the study is to identify a dose and schedule of CC-486 that can...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2015-04-29
Trial ID
NCT02343536
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
To evaluate the benefit of a precision medicine based strategy (targeted th...
Status
Not Yet Recruiting
Location
University Hospital Brno
Start Date
2026-09-01
Trial ID
NCT07522801
Treatments Being Tested
The main objective is to determine the safety and tolerability of combinati...
Status
Completed
Location
Washington University School of Medicine
Start Date
2010-05
Trial ID
NCT01001143
Treatments Being Tested
There is evidence of involvement of checkpoint pathways, including PD-1, in...
Status
Terminated
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2017-05-25
Trial ID
NCT03259516
This is an open-label, Phase 1/2a, dose-finding study with an initial phase...
Status
Recruiting
Location
University of Virginia
Start Date
2018-05-30
Trial ID
NCT03161223
Treatments Being Tested
The purpose of this study is to determine the clinical benefit of XY0206 th...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-06-15
Trial ID
NCT05876832
Treatments Being Tested
Trial Design This is an open label, single-arm, phase IB/II trial to evalua...
Status
Withdrawn
Location
UPMC Hillman Cancer Center
Start Date
2018-09-30
Trial ID
NCT03182894